Key Findings

The study identifies mutations in ampR and rpoB that contribute to the decline of ceftazidime resistance in Pseudomonas aeruginosa under antibiotic-free and sublethal tobramycin environments. These mutations result in reduced β-lactamase activity and restored RpoB functionality, leading to decreased resistance.